Day: February 5, 2024

DUBAI: H.H. Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of Dubai Health, opened today Medlab Middle East at the Dubai World Trade Centre.

The event, concluding on February 8th, reigns as the region’s biggest medical laboratory exhibition and congress, holding immense significance in propelling the field of laboratory medicine forward, both regionally and internationally.

H.H. Sheikh Mansoor was accompanied by Helal Saeed Al Marri, Director General of Dubai’s Department of Economy and Tourism, during his visit to the exhibition. He visited the pavilions of the USA, Germany, and Spain, besides the stands of Pure Lab, Revvity, Abbott, Babirus and Beckman Coulter among others.

The 2024 edition features over 900 exhibiting companies from more than 40 countries, showcasing the latest laboratory innovations across eight product categories, namely Disposables and Consumer Goods, Emergency Medicine, Imaging and Diagnostics, Healthcare and General Services, IT, Laboratory, Medical Equipment and
Devices, and Pharma and Nutrition.

Commenting on the opening of the 23rd edition of Medlab Middle East, Tom Coleman, Exhibition Director, said, ‘Last year was a record-breaking year for Medlab Middle East, where AED1.9 billion of deals were secured. Following on from this success, we are expecting a 20 percent increase in visitor numbers this year, with an estimated 30,000 attendees, and we have some exciting new additions to the event, which will elevate opportunities for knowledge-sharing and business-building even further.’

Underscoring Medlab Middle East’s commitment to innovation, a new NextGen Medicine Zone and Conference has been added to the exhibition this year in partnership with Bahrain-based Express Med Diagnostics. The NextGen Medicine zone occupies 1,500 square metres of exhibition space and features over 100 exhibitors, while a new NextGen Medicine track has been added to the Medlab Middle East Congress.

The Medlab Middle East Congress is the region’s only multi-disciplinary congress and pro
vides 12 CME-accredited live in-person conferences led by more than 130 laboratory industry experts from around the world. Running throughout the four-day exhibition, conference tracks include NextGen Medicine, Laboratory Management, Lab Quality Management, Clinical Chemistry, Immunology, Haematology, Clinical Microbiology, Clinical Genomic Interpretation, Blood Transfusion Medicine, Histapathology, Future of Lab, and Sustainability in the Lab.

On the opening morning of Medlab Middle East, growth strategy consulting firm Frost and Sullivan hosted a think tank on ‘Strategic Investments and Growth Opportunities: Reshaping the Future of Laboratories and Diagnostics Industry in the Middle East.’

Attended by representatives from Abbott, Randox, Thermo Fisher Scientific and Cleveland Clinic, the distinguished panel of healthcare leaders at the think tank addressed key industry topics including the key drivers and challenges for the laboratories and diagnostics sectors in the Middle East, and which technologies
are expected to drive growth in the industry in the years ahead.

In other sessions on the opening day, Dr Bernie Croal, President-Elect of The Royal College of Pathologists in the UK, discussed ‘Strategies to ensure that lab testing is focused and safe’ at the Laboratory Management Conference, while Dr Lubna AlZadjali, Consultant Hematopathologist from the Sultan Qaboos Comprehensive Cancer Centre in Muscat, spoke at the Haematology Conference on Haematology laboratory information systems.

Source: Emirates News Agency

ABU DHABI: Cleveland Clinic Abu Dhabi, part of the M42 network, has reinforced its vision to deliver world-class, multidisciplinary complex care that leverages future-first technologies, with the introduction of more than 20 pioneering medical and surgical innovations in 2023 across areas such as oncology, neurology, transplant, heart, vascular and thoracic care

As the ‘hospital of the future’, Cleveland Clinic Abu Dhabi uses innovation and the latest medical advances, technologies and methodologies to improve patient outcomes by optimising and targeting treatments, minimising any negative effects and enhancing patient experience.

The hospital, which is also a part of the Cleveland Clinic global enterprise, is in a unique position to drive innovation as an instrumental part of the network of M42, a first-of-its-kind health powerhouse and global health partner committed to reshaping the future of health with technology as a key enabler.

Its multidisciplinary approach, team of global experts, and world-class
services continue to provide complex care and personalised healthcare interventions that enhance patient outcomes close to home.

The hospital has adopted multiple systems powered by artificial intelligence (AI), a key transformative force in healthcare, across its institutes to enhance its complex care offerings. Within the Fatima bint Mubarak Centre, a first-of-its-kind dedicated, integrated and stand-alone cancer centre in the UAE, the Transpara system taps a sophisticated algorithm during breast cancer screenings to provide immediate feedback on areas of suspicion, increasing the accuracy of cancer detection. Adaptive radiotherapy, which uses AI and machine learning to adapt a patient’s treatment plan, is also used at the facility during the treatment of pelvic, abdominal, bladder and prostate cancers to adapt treatment plans in real-time, significantly reducing treatment time and radiation exposure.

This allows physicians to adapt a patient’s daily treatment – a process that was previously considered im
possible – to be done within minutes.

Another disruptive medical technology available at Cleveland Clinic Abu Dhabi is the ARTIS Icono advanced stroke intervention system that uses artificial intelligence to power 2D and 3D imaging for patients.

It transforms the traditional manual approach of stroke care to unparalleled AI-enabled image quality and reconstruction in real-time, which allows surgeons to skip a CT scan and begin treatment immediately. This saves precious time, gives surgeons far better visibility, and exposes the patient to less harmful radiation.

A robotic surgical system employed for highly precise and minimally invasive surgeries, like robot-assisted kidney transplants, offers benefits such as enhanced precision, reduced pain, minimal blood loss, smaller scars, shorter recovery times, reduced risk of infection, minimise post-operative complications and improved clinical outcomes. This represents a paradigm shift in the field of medicine and healthcare.

Dr. Jorge Guzman, Chief Executive O
fficer at Cleveland Clinic Abu Dhabi, shed light on the hospital’s vision to implement solutions at the forefront of medical innovation, ‘Advances in technology are today reshaping the boundaries of healthcare, from AI that can be used to customise treatment protocols to technologies that employ genomic data to predict the most effective treatment course for each patient.

At Cleveland Clinic Abu Dhabi, we remain committed to providing world-class complex care for our patients and increasingly, this requires the deployment of pioneering tools and expertise.

We had the opportunity to showcase our innovative efforts at Arab Health 2024 and remain eager to explore new avenues for collaboration and development with like-minded institutions.’

In recent years, advancements in technology have ushered in some of the most sustainable efforts to revolutionise healthcare across the world. New-age technologies like generative AI, virtual reality and augmented reality, and predictive analytics are accelerating routine t
asks while increasing the accuracy and effectiveness of healthcare interventions.

They are also improving access to care and enabling the use of preventative health measures to protect communities from looming threats.

Next-generation technologies are currently automating vast segments of healthcare delivery at Cleveland Clinic Abu Dhabi, enhancing operating efficiencies and elevating patient safety. The chemotherapy robot that prepares patient-specific hazardous doses is a clear example of this kind of application.

The robotic system for surgery also offers the same benefits, in addition to facilitating delicate, complex procedures through small incisions, which shortens patient recovery time.

Cleveland Clinic Abu Dhabi also continues to forge partnerships with other forward-thinking organisations to power advanced medical services and research. Its collaboration with the Department of Health – Abu Dhabi has seen the launch of the first Personalised Precision Medicine Programme for oncology in the region
.

The hospital has also joined forces with Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) to conduct research into further potential for AI-enabled healthcare, and to nurture the next generation of talent through mentorship and education opportunities.

Cleveland Clinic Abu Dhabi’s commitment to innovation also comes from within M42. In 2023 M42 released Med42, an open-access 70 billion parameter generative AI Clinical Large Language Model. This cutting-edge technology is poised to revolutionise clinical decision-making, providing a substantial boost to healthcare professionals, patients and medical researchers by facilitating access to synthesised medical knowledge.

These forward-looking integrations align with the technology-first mindset, showcasing Cleveland Clinic Abu Dhabi’s proactive approach to leveraging state-of-the-art technologies. By prioritising innovation, the hospital aims to elevate patient care standards and enhance overall health outcomes.

Given its strong background in
leading futuristic technology solutions, Cleveland Clinic Abu Dhabi was identified as a key partner for Arab Health Exhibition and Conference 2024 and played a significant role in designing the first-of-its-kind Smart Hospital and Interoperability Zone, which showcased the next generation of healthcare to visitors.

Source: Emirates News Agency